Systemic CD4+ T cell phenotype and activation status in intermediate uveitis
Open Access
- 1 March 2004
- journal article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 88 (3), 412-416
- https://doi.org/10.1136/bjo.2003.028506
Abstract
Aim: To investigate peripheral blood lymphocyte phenotype in patients with intermediate uveitis using CD69, chemokine receptor, and cytokine expression. Methods: Peripheral blood lymphocytes of 18 patients with idiopathic intermediate uveitis and 6 patients with presumed sarcoid intermediate uveitis were evaluated for CD4+ T cell expression of CD69, CCR4, CCR5, CXCR3 and the intracellular cytokines IFNγ, TNFα, and interleukin (IL)-10 by flow cytometry, and for IL-2, IL-4, IL-5, IL-10, IFNγ, and TNFα production following unstimulated and activated culture using cytokine bead array and compared with healthy control subjects. Results: The expression of CD69 and TNFα by peripheral blood CD4+ lymphocytes of patients with idiopathic intermediate uveitis and presumed sarcoid intermediate uveitis was significantly higher than control subjects (p = 0.002 and pConclusions: This study implicates TNFα in the pathogenesis of intermediate uveitis, highlighting the potential role of anti-TNF treatments for this disease. Studies of Th1:Th2 cytokine ratios suggested polarisation of the immune response towards Th1 in presumed sarcoid intermediate uveitis despite clinically quiescent systemic disease.Keywords
This publication has 28 references indexed in Scilit:
- Effect of infliximab on sight-threatening panuveitis in Behcet's diseaseThe Lancet, 2001
- Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergicsJournal of Immunological Methods, 2001
- Etanercept therapy in children with treatment-resistant uveitisArthritis & Rheumatism, 2001
- Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosisThorax, 2001
- CD69 expression on peripheral CD4+ T cells parallels disease activity and is reduced by mycophenolate mofetil therapy in uveitis.2001
- TH1/TH2 and TC1/TC2 profiles in peripheral blood and bronchoalveolar lavage fluid cells in pulmonary sarcoidosisJournal of Allergy and Clinical Immunology, 2001
- Infliximab and Methotrexate in the Treatment of Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Aqueous and Serum Interferon γ, Interleukin (IL) 2, IL-4, and IL-10 in Patients With UveitisAmerican Journal of Ophthalmology, 2000
- Soluble ICAM-1 serum levels in patients with intermediate uveitisBritish Journal of Ophthalmology, 1999
- Regulation of autoimmunity by proinflammatory cytokinesCurrent Opinion in Immunology, 1998